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Abstract 
Background: The use of molecular diagnostics has revealed an unexpectedly large number of asymptomatic 
low-density malaria infections in many malaria endemic areas. This study compared the gains in parasite prevalence 
obtained by the use of ultra-sensitive (us)-qPCR as compared to standard qPCR in cross-sectional surveys conducted 
in Thailand, Brazil and Papua New Guinea (PNG). The compared assays differed in the copy number of qPCR targets in 
the parasite genome.
Methods: Plasmodium falciparum (Pf) and Plasmodium vivax (Pv) parasites were quantified by qPCR amplifying the 
low-copy Pf_ and Pv_18S rRNA genes or the multi-copy targets Pf_varATS and Pv_mtCOX1. Cross-sectional surveys at 
the three study sites included 2252 participants of all ages and represented different transmission intensities.
Results: In the two low-transmission areas, P. falciparum positivity was 1.3% (10/773) (Thailand) and 0.8% (5/651) (Bra-
zil) using standard Pf_18S rRNA qPCR. In these two countries, P. falciparum positivity by Pf_varATS us-qPCR increased 
to 1.9% (15/773) and 1.7% (11/651). In PNG, an area with moderate transmission intensity, P. falciparum positivity 
significantly increased from 8.6% (71/828) by standard qPCR to 12.2% (101/828) by us-qPCR. The proportions of P. 
falciparum infections not detected by standard qPCR were 33%, 55% and 30% in Thailand, Brazil and PNG. Plasmodium 
vivax was the predominating species in Thailand and Brazil, with 3.9% (30/773) and 4.9% (32/651) positivity by Pv_18S 
rRNA qPCR. In PNG, P. vivax positivity was similar to P. falciparum, at 8.0% (66/828). Use of Pv_mtCOX1 us-qPCR led to 
a significant increase in positivity to 5.1% (39/773), 6.4% (42/651) and 11.5% (95/828) in Thailand, Brazil, and PNG. The 
proportions of P. vivax infections missed by standard qPCR were similar at all three sites, with 23%, 24% and 31% in 
Thailand, Brazil and PNG.
Conclusion: The proportional gains in the detection of P. falciparum and P. vivax infections by ultra-sensitive diag-
nostic assays were substantial at all three study sites. Thus, us-qPCR yields more precise prevalence estimates for 
both P. falciparum and P. vivax at all studied levels of endemicity and represents a significant diagnostic improvement. 
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Background
Asymptomatic Plasmodium infections, persisting unde-
tected in the population, present a silent reservoir for on-
going transmission and pose a major challenge in malaria 
elimination [1]. Parasite densities in asymptomatic infec-
tions are often low, and therefore infections remain 
undetected by light microscopy (LM) or rapid diagnostic 
tests (RDT), the standard diagnostics to control malaria 
in endemic countries. In epidemiological studies, quan-
titative PCR (qPCR) has increasingly been used to obtain 
more precise prevalence rates for Plasmodium spp. 
infections [2–6]. The most widely used qPCR assays for 
detection of Plasmodium species target genus- or spe-
cies-specific regions within the 18S rRNA genes [2, 7–9]. 
The genomes of Plasmodium falciparum (Pf) and P. vivax 
(Pv) harbour 5 and 3 copies of 18S rRNA genes, however, 
some copies show substantial sequence variation so that 
primers and probes for P. vivax target only one copy of 
this gene family [10]. Comparison of the widely used 
18S rRNA assays with ultra-sensitive detection methods 
uncovered a 2–4 times higher parasite prevalence of low-
density malaria infections at medium and low transmis-
sion settings that previously remained undiagnosed by 
less sensitive detection tools [6, 11, 12].
Enhanced detection sensitivity by qPCR can be 
achieved in three ways: firstly, by processing larger vol-
umes of blood and concentrating the DNA during the 
extraction procedure [11, 13], secondly, by using ultra-
sensitive-qPCR (us-qPCR) assays that target multi-copy 
sequences in the parasite genome [10, 11, 14–16] instead 
of a single-copy or low-copy gene, and thirdly, by detect-
ing highly abundant 18S rRNA transcripts by quantita-
tive reverse-transcriptase PCR (qRT-PCR) instead of 
rDNA. Collecting a large volume of blood by venipunc-
ture instead of finger prick is mostly not feasible for large 
surveys. RNA should be preserved using specific buffers 
and stored at −  80  °C to avoid degradation. Compared 
to DNA-based tests, RNA extraction and qRT-PCR are 
more costly and the handling and amplification of the 
high copy 18S rRNA transcripts are more prone to con-
tamination [2, 10]. Both these methods are, therefore, less 
practicable for malaria surveillance. In contrast, amplify-
ing multi-copy genes by qPCR improves diagnostic sen-
sitivity even when using finger prick blood samples [11]. 
For ultra-sensitive detection of low-density P. falcipa-
rum infections, the Pf_varATS us-qPCR was developed 
that targets the acidic terminal sequences of multi-copy 
var genes [11]. For low-density P. vivax infections, Pv_
mtCOX1 us-qPCR targeting the cytochrome oxidase 1 
gene was designed [10]. COX1 is encoded in the mito-
chondrial genome and is present in at least 20 copies per 
cell [17]. Both us-qPCR assays for P. falciparum and P. 
vivax detect 10-fold lower parasite densities as compared 
to Pf_ and Pv_18S rRNA assays [10, 11].
Ultra-sensitive diagnostic methods are of particular 
importance for P. vivax, as this species generally presents 
lower levels of parasitemia compared to P. falciparum 
due to its preferential invasion of the reticulocyte, rather 
than the mature red blood cell. For example in Papua 
New Guinea (PNG), where both species are equally 
prevalent, mean P. vivax parasite densities by LM in com-
munity samples were seven times lower than those of 
P. falciparum [3]. In the context of elimination, malaria 
diagnostics may require detection of the full extent of 
carriers of both parasite species. This is of particular rel-
evance for P. vivax, as individuals with an undetected P. 
vivax infection may carry dormant hypnozoites and thus 
present a future reservoir for onward transmission due to 
later relapses.
Over the last decade, malaria epidemiological studies 
have increasingly employed molecular diagnostics, and 
PCR-based prevalence rates became available from many 
endemic areas [1, 16]. Meta-analyses have investigated 
the relationship of PCR and LM prevalence for P. falcipa-
rum and P. vivax [1, 16, 18]. For P. falciparum this analy-
sis has shown that the proportion of submicroscopic P. 
falciparum infections greatly varied according to P. fal-
ciparum transmission intensity and ranged from 20% in 
areas of high transmission to 80% in low endemicity set-
tings [1]. For P. vivax, two systematic reviews analysed 
cross-sectional studies from Asia, South America and 
South Pacific and gave concordant results [16, 18], show-
ing that PCR performed in community samples detected 
on average more than twice as many infections as LM. 
Similar to P. falciparum, the proportion of submicro-
scopic P. vivax infections was negatively correlated with 
prevalence by LM, i.e. a larger proportion of submicro-
scopic P. vivax infections was observed in low compared 
to high P. vivax transmission areas [16].
Together these earlier studies indicated that in areas of 
low malaria endemicity, molecular diagnostic methods 
are of particular importance for assessing the transmis-
sion reservoir and for informing malaria control inter-
ventions [1, 16]. The hypothesis for the current study 
Improving sensitivity in P. vivax surveillance by us-qPCR is of particular benefit, because the additionally detected P. 
vivax infections signal the potential presence of hypnozoites and subsequent risk of relapse and further transmission.
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was that us-qPCRs, compared to standard qPCRs, could 
also be particularly beneficial in low endemic areas, as 
they could further improve the precision of molecular 
prevalence estimates. The gain in additionally diagnosed 
parasite carriers by us-qPCR might also vary accord-
ing to transmission intensity, similar to the described 
larger proportion of submicroscopic P. falciparum infec-
tions found in low endemic settings [1, 16]. This study 
explored the advantage of using us-qPCR for P. falcipa-
rum and P. vivax compared to diagnosis by standard 18S 
rRNA qPCR. By analysing community samples from low 
transmission settings in Brazil and Thailand and a set-
ting of moderate transmission in PNG, the variation of 
gains across the study sites was examined, as well as the 
age distribution of submicroscopic infections by standard 
versus us-qPCR.
Methods
Study sites and archived samples
This study used 2252 archived DNA samples from cross-
sectional blood collections in Thailand, Brazil and PNG 
between 2012 and 2014. A detailed description of these 
three study sites and results by standard qPCR were 
published previously [4, 5, 19] (W. Monteiro, pers. com-
mun.). Sampling procedures, DNA extraction from red 
blood cell pellets and diagnostic tests were harmonized 
among all sites. DNA samples from participants of all 
age-groups were selected randomly from larger subsets 
from Thailand and Brazil. 773 archived DNA samples 
from Thailand originated from a low-endemic village of 
the BongTi region, Kanchanaburi province, and were col-
lected in 2012. The 651 archived DNA samples from Bra-
zil were collected in the Manaus region in March 2014. 
From PNG, the full sample sets (828 archived samples) 
from the two communities Megiar and Utu, one of high 
and one of low transmission, were analysed. These cross-
sectional surveys were conducted between May and 
July 2014 in Madang province. Prior to performance of 
us-qPCR, good quality of the stored DNA was confirmed 
by repeating species-specific Pf_ and Pv_18S rRNA qPCR 
assays in a minimum of 150 samples from each study site. 
Results in these repeated subsets were compared to the 
first round of Pf_ and Pv_18S rRNA assays [4, 5, 19]. For 
Thailand and Brazil complete overlap for P. falciparum-
positivity and almost complete overlap for P. vivax-posi-
tivity was found. For PNG P. falciparum-positivity agreed 
very well, but discrepancies were observed for P. vivax 
between first and repeat results. Therefore, all PNG sam-
ples were re-analysed by Pv_18S rRNA qPCR and only 
the data from repeats were used for the comparison of 
diagnostic methods.
qPCR and us‑qPCR
The three sets of samples were analysed in their respec-
tive countries of origin. For quantification of P. falcipa-
rum parasites in sample sets from Thailand and Brazil, 
a dilution of the WHO International Standard “Plasmo-
dium falciparum DNA for NAT Assays” (NIBSC, UK) 
was used. For quantification of P. falciparum parasites in 
the PNG sample set, a serial dilution of cultured 3D7 par-
asites was used. Plasmodium vivax samples were quanti-
fied using a standard curve generated from dilutions of P. 
vivax control plasmids containing inserts corresponding 
to the respective qPCR or us-qPCR target sequences [2, 
10].
Pf_ and Pv_18S rRNA qPCR was performed at all 
sites with the same protocols [2]. The same applies for 
Pf_varATS and Pv_mtCOX1 us-qPCR assays [10, 11], 
the performance of which is summarized in Table  1. 
For a comparison of parasite densities between study 
sites, qPCR efficiency and sensitivity of each assay was 
analysed across laboratories (Additional file 1: Table S1, 
Additional file 2: Fig. S1). Except for 5 Brazilian samples 
that were initially positive by Pf_18S rRNA qPCR, suffi-
cient DNA for us-qPCR was available for all samples. In 
the comparative analysis of overall prevalence by varATS 
Table 1 Molecular diagnostic assays used in this study
a LOD for Pf_varATS qPCR determined by a serial dilution of the WHO International Standard (presented as parasites/µL whole blood, reconstituted using WHO 
international standard together with uninfected blood); LOD for Pv_mtCOX1 determined in two trendlines generated from LM-quantified field samples (presented as 
parasites/µL whole blood from field samples)
Molecular assays Target gene Amplicon length 
(bp)
Target copies/parasite 
genome
LODa (parasite/µL) References
P. falciparum qPCR
 Pf_18S rRNA 18S rRNA genes 221 3 1.57 [2]
 Pf_varATS var genes 65  ≥ 59 0.06–0.15 [11]
P. vivax qPCR
 Pv_18S rRNA 18S rRNA gene 221 1 0.13–0.92 [2, 12]
 Pv_mtCOX1 mtCOX1 148  > 20 0.01–0.023 [10, 12]
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qPCR across the three sites, these 5 Brazilian samples 
were included and considered positive, justified by their 
original Pf_18S rRNA qPCR positivity and by data from 
Thailand and PNG, where 100% (Thailand) or 98% of 
18S rRNA-positives (PNG) were also positive by varATS 
qPCR (Additional file 2: Fig. S2). In the analysis of para-
site densities, the quantification of these 5 samples were 
based on the earlier Pf_18S rRNA qPCR data.
Data analysis
Data were analysed using R.Studio version 3.5.1. Parasite 
densities determined by standard qPCR and us-qPCR 
assays were log10 transformed and presented as median 
densities, if not stated otherwise. A febrile malaria case 
was defined as an individual with fever or history of 
fever (body temperature ≥ 37.5  °C at blood sampling or 
within the preceding 2 days) and microscopic detection 
of parasites. Proportions of samples positive by stand-
ard 18S rRNA qPCR and us-qPCR were compared using 
McNemar´s  Chi2 test. A linear regression model was 
used to evaluate the difference of proportional gains by 
us-qPCR among the 3 study sites.
Results
Plasmodium falciparum‑positivity by qPCR and us‑qPCR
By standard Pf_18S rRNA qPCR, positivity was signifi-
cantly higher in PNG compared to the other field sites 
 (Chi2–test, p < 0.001). The absolute number of addition-
ally detected P. falciparum infections by us-qPCR was 
highest in PNG, the site with intermediate transmission 
intensity. The relative proportion of additionally detected 
P. falciparum infections differed substantially between 
Brazil (55%, 95% CI 25–82) and Thailand (33%, 95% CI 
13–61) and PNG (30%, 95% CI 21–40) (Table 2, Fig. 1a, 
c), but owing to the small number of P. falciparum 
samples at the sites of low endemicity, these differences 
in gains were not statistically significant (p = 0.77).
Plasmodium vivax prevalence by qPCR and us‑qPCR
Plasmodium vivax was the prevailing species in Thai-
land and Brazil with 3.9% (30/773) and 4.9% (32/651) 
Pv_18S rRNA-positive individuals. Pv_18S rRNA positiv-
ity at these field sites was significantly lower than in PNG 
(8.0%, 66/828,  Chi2-test, p < 0.001) (Table  2), where P. 
vivax and P. falciparum prevalence rates were compara-
ble (Table 2). The absolute number of P. vivax infections 
that were additionally detected by Pv_mtCOX1 us-qPCR 
was highest in PNG (Table 2), which in global compari-
son represents particularly high P. vivax prevalence. The 
proportion of P. vivax infection additionally detected 
by us-qPCR was similar in low endemic Thailand (23%, 
95% CI 12–40) and Brazil (24%, 95% CI 13–40), but was 
higher in PNG (31%, 95% CI 22–41) (Fig.  1b). By us-
qPCR P. falciparum/P. vivax co-infections were detected 
in 4.1% (34/828) individuals from PNG and in 0.6% 
(5/773) individuals from Thailand, whereas no co-infec-
tion was observed in Brazil.
Plasmodium falciparum and P. vivax densities
Quantification by us-qPCR was reliable as shown by 
a good correlation with quantification by 18S rRNA 
qPCR (Additional file  2: Fig. S3). Characteristics of 
both us-qPCR assays that are relevant for quantifica-
tion, agreed well between the different laboratories 
(Additional file  1: Table  S1, Additional file  2: Fig. S1), 
hence, between-site comparisons of parasite densities 
by us-qPCR are appropriate. In contrast, densities of 
P. falciparum and P. vivax by us-qPCR cannot be com-
pared directly for several reasons: Firstly, both multi-
copy assays target different numbers of gene copies 
Table 2 P. falciparum and P. vivax positivity in community samples from Thailand, Brazil and PNG, determined by species-
specific 18S rRNA (qPCR) versus ultra-sensitive qPCR (us-qPCR)
a McNemar’s  Chi2-test used to determine if gain of infections by us-qPCR was significant
P. falciparum positivity (%) P. vivax positivity (%)
qPCR
(95% CI)
(n/N)
us‑qPCR
(95% CI)
(n/N)
p‑valuea qPCR
(95% CI)
(n/N)
us‑qPCR
(95% CI)
(n/N)
p‑valuea
Thailand 1.3%
(0.7–2.5)
(10/773)
1.9%
(1.1–3.3)
(15/773)
0.074 3.90%
(2.7–5.6)
(30/773)
5.00%
(3.7–6.9)
(39/773)
0.008
Brazil 0.80%
(0.3–1.9)
(5/651)
1.70%
(0.9–3.1)
(11/651)
(11/651)
0.041 4.90%
(3.4–6.9)
(32/651)
6.50%
(4.7–8.7)
(42/651)
0.004
PNG 8.60%
(6.8–10.7)
(71/828)
12.20%
(10.1–14.7)
(101/828)
 < 0.001 8.00%
(6.3–10.1)
(66/828)
11.50%
(9.4–13.8)
(95/828)
 < 0.001
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per genome, thus, a comparison based on numbers 
of detected gene copies/µL would be disproportion-
ate. Secondly, P. falciparum densities were reported as 
parasites/µL blood by converting Ct-values determined 
by Pf_varATS us-qPCR into parasite numbers using a 
parasite trendline, whereas for P. vivax, owing to the 
lack of in vitro culture, a well-defined P. vivax parasite 
trendline was not available for absolute parasite quan-
tification. Instead, P. vivax densities were derived from 
a dilution series of a plasmid standard and reported 
as Pv_mtCOX1 copy numbers/µL blood. While densi-
ties of P. falciparum and P. vivax are not comparable 
between species, the median densities of either species 
are well comparable between field sites. For all coun-
tries, P. falciparum and P. vivax densities by us-qPCR 
were stratified according to a sample’s positivity by 
either of the qPCR assays or both assays. (Table 3 and 
Fig. 1c, d).
The median parasite density of P. falciparum infec-
tions detected by Pf_18S rRNA qPCR was highest in 
low-endemic Thailand, but significantly lower in low-
endemic Brazil and moderate-endemic PNG (Table 3). 
This difference in median density may be attributed 
to symptomatic cases in the Thai sample set. When 
all symptomatic P. falciparum infections with densi-
ties > 1000 parasites/µL (3/15) were excluded from the 
analysis of Thai community samples, the median P. fal-
ciparum density decreased from 238.9 parasites/µL to 
11.2 parasites/µL (IQR: 0.2–102.3 parasites/µL). These 
densities from asymptomatic Thai study participants 
are in the same range as densities observed in PNG and 
Brazil (Fig. 1c). In all three settings, parasite densities in 
infections detected only by us-qPCR were 10–20 times 
Fig. 1 Proportion of P. falciparum and P. vivax infections detected by qPCR versus us-qPCR by country. Proportion of P. falciparum (a) and P. vivax 
infections (b) positive by species-specific 18S rRNA qPCR among all samples positive by any qPCR assay (standard qPCR or us-qPCR) and parasite 
densities of P. falciparum (c) and P. vivax infections (d) detected by 18S rRNA qPCR versus only by us-qPCR. White circles: infection detected by 
standard qPCR; black circles: infection detected only by us-qPCR. 1Owing to exhaustion of DNA, the parasite densities of 5 Brazilian samples (white 
circles) were quantified by 18S rRNA qPCR
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lower than densities in infections only positive by the 
less sensitive Pf_18S rRNA qPCR (p < 0.001) (Table 3).
Just as for P. falciparum, P. vivax parasite densities in 
infections only detected by us-qPCR were 8–10 times 
lower than densities in P. vivax infections detected by 
Pv_18S rRNA qPCR (p < 0.001) (Table  3, Fig.  1d). The 
median P. vivax parasite density in P. vivax-positives 
detected by Pv_18S rRNA qPCR was 11-fold lower in 
community samples from PNG than in those from 
Thailand, and 16-fold lower than in Brazil (p < 0.05) 
(Table 3). Similarly, the median P. vivax density in sam-
ples only positive by us-qPCR was significantly lower 
in PNG compared to Thailand and Brazil (p < 0.05) 
(Table 3).
Age trends of P. falciparum and P. vivax infections
To identify population sub-groups that harbour particu-
larly low-density infections and where benefits from us-
qPCR would thus be greatest, parasite prevalence and 
density was analysed with respect to age. In all study 
sites, P. vivax positivity varied by age. This trend was con-
sistent by both diagnostic assays. The age-stratified prev-
alence rates generated by the two molecular assays did 
not differ significantly at any study site  (Chi2; Thailand: 
Table 3 P. falciparum and P. vivax densities stratified according to positivity by standard 18S rRNA qPCR (qPCR), by any 
qPCR, or only by ultra- sensitive qPCR (us-qPCR)
a Log10 transformed median parasite density quantified by us-qPCR
b Owing to exhaustion of DNA, parasite densities of 5 of the Brazilian samples were quantified by 18S rRNA qPCR
Country P. falciparum Median  Densitya
Parasites/µL (IQR)
P. vivax Median  Densitya
Pv_mtCOX1 copies/µL (IQR)
qPCR( +) qPCR( +) 
and us‑qPCR( +)
qPCR(‑) 
and us‑qPCR( +)
qPCR( +) qPCR( +) 
and us‑qPCR( +)
qPCR(‑) and us‑qPCR( +)
Thailand 238.9 (55.8–1519) 40.8 (0.5–536.2) 0.2 (0.2–0.2) 104.8 (24.9–246.7) 50.4 (4.9–190.8) 3.1 (0.9–7.6)
Brazil 4.0b (1.9–125.4) 0.4b (0.2–3.0) 0.2 (0.1–0.3) 152.6 (50.3–738.7) 79.8 (18.3–464.4) 7.3 (3.7–22.0)
PNG 5.7 (1.0–70.0) 1.9 (0.2–22.5) 0.1 (0.0–0.4) 9.5 (3.1–145.9) 3.7 (0.9–16.4) 0.7 (0.3–1.2)
Fig. 2 Age trends in P. vivax positivity and parasite density in Thailand, Brazil and PNG. P. vivax infections detected by Pv_18S rRNA qPCR and 
Pv_mtCOX1 us-qPCR (white circles) and P. vivax infections only detected by Pv_mtCOX1 us-qPCR (black circles). a–c P. vivax positivity by age group 
with 95% confidence intervals (black vertical lines). d–f  Log10 transformed P. vivax parasite density by Pv_mtCOX1 us-qPCR per age group with 
median Pv_mtCOX1 copy numbers (horizontal lines)
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p-value = 0.96, Brazil: p = 0.79, PNG: p = 0.73). In Thai-
land and Brazil, P. vivax prevalence by both, standard and 
us-qPCR, peaked in adults aged 20–60 years (Fig. 2a, b), 
whereas in PNG prevalence was highest by both assays in 
adolescents aged 10–20 years (Fig. 2c). No P. vivax infec-
tion was found in the youngest age group in Brazil and 
Thailand (0–3  years), whereas P. vivax infections were 
detected by both assays in children from PNG aged 0–3 
years (Fig. 2a–f). Plasmodium vivax infections were also 
absent in Thai children aged 3–5 years. At all three sites, 
median P. vivax densities measured by Pv_mtCox1 cop-
ies/µL blood were highest in the youngest age groups 
that included P. vivax-positive individuals, and tended 
to decrease by age (Fig.  2d–f). These trends were not 
statistically significant owing to the limited number of P. 
vivax-positive individuals in some age groups.
Age trends for P. falciparum prevalence and parasite 
density in Thailand and Brazil could not be analysed 
because of the limited number of P. falciparum-positive 
individuals. For PNG, the age distribution of P. falcipa-
rum infections is shown in Additional file 2: Fig. S4.
Discussion
This study investigated the extent of low-density P. fal-
ciparum and P. vivax infections in moderate and low 
transmission settings in Thailand, Brazil and PNG, using 
ultra-sensitive detection assays. The LODs of the P. falci-
parum and P. vivax us-qPCR assays, which was 10-times 
lower than the standard assay Pf_18S rRNA qPCR [10, 
11] were in good agreement between the three labora-
tories. The inter-laboratory comparability of results was 
closely controlled by the use of external reference stand-
ards. To evaluate the usefulness of us-qPCR assays for 
epidemiological studies, age trends in prevalence rates 
were analysed. No differences were observed in age-
dependent epidemiological pattern in prevalence nor 
density in any transmission setting, thus confirming the 
suitability of us-qPCR for epidemiological research.
Substantial differences in gains were observed across 
transmission settings. For example, at the PNG study site, 
P. falciparum prevalence in the community increased 
from 8.6% to 12.2% by us-qPCR, an increase of 30% in P. 
falciparum positivity. In Brazil P. falciparum prevalence 
was much lower and a two-fold gain was observed in the 
proportion of positive samples by use of the ultra-sensi-
tive varATS assay. However, the absolute numbers of P. 
falciparum infections in this comparative study were 
too low (i.e. a rise from 6/651 to 11/651 P. falciparum-
positive individuals) so that the difference between study 
sites in the proportional gains was not statistically signifi-
cant. The question whether proportional gains are higher 
at very low P. falciparum transmission intensity remains 
to be clarified by a larger study with a sufficient P. 
falciparum sample size for statistical analysis. Gains that 
differ by transmission intensity could occur if low-density 
P. falciparum infections undetectable by standard Pf_18S 
rRNA qPCR, would be relatively more abundant in low 
compared to high transmission. Earlier meta-analyses of 
global prevalence data of both, PCR- and microscopy-
based diagnosis [1, 16] had revealed a negative relation-
ship of the proportion of submicroscopic infections with 
transmission intensity.
The seemingly lower proportional gain in PNG com-
pared to the Brazilian site (30% versus 55%) might be 
related to slightly higher overall P. falciparum parasite 
densities in community samples from PNG (1.9 para-
sites/µL) compared to Brazil (0.4 parasites/µL). The small 
difference in median P. falciparum densities between 
PNG and Brazil is in proximity to the LOD of the Pf_18S 
rRNA assay (1.57  parasites/µL blood) and therefore 
could have caused a higher proportion of infections in 
PNG samples to be detectable by standard Pf_18S rRNA 
qPCR. Whether density differences between sites could 
explain the smaller gains in PNG by using us-qPCR 
remains unclear, as the limited number of P. falciparum 
cases from low endemic Brazil precludes clarification of 
reasons for differing proportional gains.
Among all three sites, the P. falciparum median den-
sity was highest in Thailand with 238 parasites/µL com-
pared to 4.0 parasites/µL in Brazil. This was due to very 
few high density infections with > 1000 parasites/µL in 
this community. In addition, 3 of these P. falciparum-
infected cases showed evidence of fever within the pre-
ceding 2 days. These findings from Thailand could mirror 
declining transmission and indicate that less frequent 
exposure to P. falciparum may result in waning immunity 
against this parasite. This would suggest that P. falcipa-
rum-infected individuals at the Thai study site more often 
develop high parasite densities and become symptomatic 
and thus will receive treatment. It, therefore, can be spec-
ulated that the presence of malaria episodes has caused 
a lower proportional gain of infections detected by us-
qPCR in Thailand compared to low-endemic Brazil.
Pv_mtCOX us-qPCR resulted in an analogical increase 
in the proportion of additionally detected P. vivax-infec-
tions across all study sites, ranging from 31% in PNG 
to 24% in Brazil and 23% in Thailand. Compared to the 
more pronounced differences in P. falciparum propor-
tional gains, the Pv_mtCOX-based increase was similar 
across the 3 sites. When P. vivax median densities were 
consulted to explain the small difference in proportional 
gains between study sites, 11–16-fold higher P. vivax 
densities were observed in Brazil and Thailand compared 
to PNG. This might be responsible for the lower gain 
by more sensitive diagnostics in these two low endemic 
settings.
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Benefits from us-qPCR consist in the improved detec-
tion of low-density P. falciparum and P. vivax infections. 
The question arises, whether these low-density infections 
carry gametocytes in sufficient numbers to contribute 
to onward transmission to mosquitoes. This question 
has been addressed by previous studies at all three sites, 
either by membrane feeding assays on symptomatic 
blood samples [20, 21] or by using gametocyte density as 
surrogate for transmission potential, such as in a study 
recently performed in the same community in PNG, 
where gametocytes were quantified after enrichment 
from large volumes of blood [12]. In this recent study, 
more than half of the P. falciparum- and P. vivax-positive 
samples that were only detected by us-qPCR, carried 
gametocytes, (10 gametocyte carriers in 15 P. falcipa-
rum-infections and 11 gametocyte carriers in 19 P. vivax-
infections) [12]. Gametocyte densities were tenfold lower 
in infections detected by standard 18S rRNA qPCR com-
pared to infections only detectable by us-qPCR and were 
below 1 male and 1 female gametocyte/µL [22]. Although 
the gametocyte sex-ratio suggested a very low likelihood 
of transmission [22], it cannot be excluded that parasite 
densities in untreated, chronic malaria infections in the 
community may fluctuate and transiently reach levels 
that could potentially be infective to mosquitoes [23].
A limitation in the quantification of P. vivax infections 
derives from differences in the numbers of mitochondria 
between different P. vivax blood stages, i.e. between a 
ring stage versus a multi-nucleated schizont stage, both 
present in peripheral blood. The number of target gene 
copies per parasite varies accordingly [10] [17]. Plasmo-
dium vivax parasite densities calculated from qPCR copy 
numbers thus represent only an estimate. Yet, this equally 
applies to the variable number of nuclear genomes and 
thus to 18S rDNA copies circulating in P. vivax parasites 
of any stage. This explains our observation of a good cor-
relation between both markers for quantification of P. 
vivax. For other human Plasmodium species occurring at 
the 3 study sites, us-qPCR assays have not yet been devel-
oped, thus the analyses performed in this study were lim-
ited to P. falciparum and P. vivax.
Investigations of individuals at greatest risk of infec-
tion based on parasite detection by Pf_ and Pv_18S rRNA 
qPCR assays have been described previously for all three 
study sites [19, 24] [W. Monteiro, personal communica-
tion]. These earlier analyses showed that main predictors 
of P. falciparum and P. vivax infections and density dif-
fered substantially between sites. To complement these 
former epidemiological analyses, age trends of P. falcipa-
rum and P. vivax infection in relation to parasite densities 
based on us-qPCR data were investigated. Parasite car-
riers with very low-density infections in PNG were pri-
marily found in adolescents aged 10–20 years, whereas in 
Thailand and Brazil most additionally gained infections 
were found in older individuals (> 40 years of age). There-
fore, the additional P. vivax infections detected by us-
qPCR coincided with the age group that had presented 
the highest risk of infection in earlier analyses from Thai-
land, Brazil and PNG [19, 24] (W.M. Monteiro, pers. 
commun.).
Depending on the public health question to be 
addressed by molecular diagnosis, more precise preva-
lence data as achieved by us-qPCR may be of consider-
able relevance, particularly in low transmission settings, 
where each individual malaria case is investigated by 
elimination programmes [25]. Furthermore, results are 
likely to be more consistent across surveys, as stochastic 
amplification of low-density infections is reduced [2, 11]. 
Because this study demonstrated a substantial gain of 
additionally detected low-density infections, particularly 
in low transmission settings, us-qPCR could be crucial 
for surveillance in elimination settings. Molecular diag-
nosis is increasingly used to determine presence of infec-
tions to guide control efforts [26]. The use of us-qPCR, 
and thus greater confidence in diagnostic metrics, could 
reduce the number of samples to be screened before 
declaring a region malaria-free.
Conclusion
The use of us-qPCR for parasite detection in the com-
munity provided a more accurate picture of low-density 
infections at different levels of transmission intensity. The 
benefits of using ultra-sensitive assays were clearly dem-
onstrated for all study sites. When analysing the relation-
ship of low versus high transmission intensity and the 
gain in P. vivax positivity by us-qPCR, only minor differ-
ences were observed between study sites in the P. vivax 
proportional gains in positivity that ranged from 23% 
to 31%. The P. falciparum proportional gain was almost 
twice as high in Brazil (low P. falciparum transmission) 
than in PNG (high P. falciparum transmission). How-
ever, this difference was not statistically significant, as 
the absolute number of P. falciparum positive samples 
in the Brazilian community survey was as low as 1.7% 
(11/651) by P. falciparum us-qPCR. Further comparative 
studies are required to clarify a potentially higher gain in 
P. falciparum positivity in low transmission versus high 
transmission.
In areas of low P. falciparum and P. vivax transmission, 
the absolute number of infections additionally gained 
by ultra-sensitive methods seem few. However, for cer-
tain research questions arising in pre-elimination set-
tings, such increased sensitivity might be beneficial for 
informing control measures. For instance, Pv_us-qPCR 
can play an important role in both epidemiological stud-
ies and surveillance, because those additionally detected 
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Pv-positive individuals may experience relapses and in 
future contribute to onwards transmission.
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